Cargando…

Redefining risk research priorities for nanomaterials

Chemical-based risk assessment underpins the current approach to responsible development of nanomaterials (NM). It is now recognised, however, that this process may take decades, leaving decision makers with little support in the near term. Despite this, current and near future research efforts are...

Descripción completa

Detalles Bibliográficos
Autores principales: Grieger, Khara D., Baun, Anders, Owen, Richard
Formato: Texto
Lenguaje:English
Publicado: Springer Netherlands 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988212/
https://www.ncbi.nlm.nih.gov/pubmed/21170127
http://dx.doi.org/10.1007/s11051-009-9829-1
_version_ 1782192235210604544
author Grieger, Khara D.
Baun, Anders
Owen, Richard
author_facet Grieger, Khara D.
Baun, Anders
Owen, Richard
author_sort Grieger, Khara D.
collection PubMed
description Chemical-based risk assessment underpins the current approach to responsible development of nanomaterials (NM). It is now recognised, however, that this process may take decades, leaving decision makers with little support in the near term. Despite this, current and near future research efforts are largely directed at establishing (eco)toxicological and exposure data for NM, and comparatively little research has been undertaken on tools or approaches that may facilitate near-term decisions, some of which we briefly outline in this analysis. We propose a reprioritisation of NM risk research efforts to redress this imbalance, including the development of more adaptive risk governance frameworks, alternative/complementary tools to risk assessment, and health and environment surveillance.
format Text
id pubmed-2988212
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-29882122010-12-15 Redefining risk research priorities for nanomaterials Grieger, Khara D. Baun, Anders Owen, Richard J Nanopart Res Perspectives Chemical-based risk assessment underpins the current approach to responsible development of nanomaterials (NM). It is now recognised, however, that this process may take decades, leaving decision makers with little support in the near term. Despite this, current and near future research efforts are largely directed at establishing (eco)toxicological and exposure data for NM, and comparatively little research has been undertaken on tools or approaches that may facilitate near-term decisions, some of which we briefly outline in this analysis. We propose a reprioritisation of NM risk research efforts to redress this imbalance, including the development of more adaptive risk governance frameworks, alternative/complementary tools to risk assessment, and health and environment surveillance. Springer Netherlands 2009-12-24 2010-02 /pmc/articles/PMC2988212/ /pubmed/21170127 http://dx.doi.org/10.1007/s11051-009-9829-1 Text en © Springer Science+Business Media B.V. 2009
spellingShingle Perspectives
Grieger, Khara D.
Baun, Anders
Owen, Richard
Redefining risk research priorities for nanomaterials
title Redefining risk research priorities for nanomaterials
title_full Redefining risk research priorities for nanomaterials
title_fullStr Redefining risk research priorities for nanomaterials
title_full_unstemmed Redefining risk research priorities for nanomaterials
title_short Redefining risk research priorities for nanomaterials
title_sort redefining risk research priorities for nanomaterials
topic Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988212/
https://www.ncbi.nlm.nih.gov/pubmed/21170127
http://dx.doi.org/10.1007/s11051-009-9829-1
work_keys_str_mv AT griegerkharad redefiningriskresearchprioritiesfornanomaterials
AT baunanders redefiningriskresearchprioritiesfornanomaterials
AT owenrichard redefiningriskresearchprioritiesfornanomaterials